Lurasidone Pediatric Bipolar Study

Clinical trial NCT02046369 · COMPLETED

Trial details

NCT number: NCT02046369
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar I Depression

Start date: 2014-03-01
Primary completion: 2016-10-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.